Search

You searched for "lid"

1706 results found

Scope Ophthalmology announce case awards winners

11 September 2023 | Awards, Conferences & Anniversaries
Scope Eyecare are delighted to announce the winners of the Scope Ophthalmology case awards UK and Ireland for 2023.

Surgitrac Instruments at the 43rd Congress of the ESCRS: A Successful Event in Copenhagen

22 September 2025 | Company Profiles, Awards, Conferences & Anniversaries
Surgitrac Instruments was proud to exhibit at the 43rd Congress of the ESCRS in the beautiful city of Copenhagen. This year’s congress was a fantastic opportunity to connect with ophthalmic professionals from around the world, share ideas, and showcase our...

Stem cell therapy for Parkinson’s disease: researching for an 
effective cure

1 December 2015 | | EYE - Neuro-ophthalmology
Neurodegenerative diseases are characterised by the chronic and progressive loss of neurons, which in turn results in loss of cognitive and physical functions. The World Health Organization has estimated that the disability-adjusted life years lost from neurological disease was about...

Nano-ophthalmology paves a new path in the future of eyecare

1 December 2022 | | EYE - General
Introduction The treatments of ocular conditions in the field of ophthalmology varies from topical to surgical procedures. The field of nanotechnology is one of the fast-growing fields of medicine, which plays an important role in turning the impossibilities of the...

An update on inherited retinal disorders (part 1) – overview and assessment of inherited retinal disease

1 October 2016 | | EYE - Vitreo-Retinal
Part 2 of this topic can be found here Inherited Retinal Disease (IRD) is the leading cause of blindness certification in the working age population (age 16-64 years) in England and Wales and the second most common in childhood [1]....

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)

3 April 2023 |
Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...

Aqueous misdirection: a case series of unexpected surgical complications

3 June 2024 | | EYE - Glaucoma
Aqueous misdirection (AM), also known as malignant glaucoma, is a form of secondary glaucoma that typically presents with shallowing of the anterior chamber (AC), raised intraocular pressure (IOP), and reduced visual acuity (VA) in the presence of patent peripheral iridotomies...

Corneal hysteresis: An emerging biomarker in the management of glaucoma

2 October 2025 | | EYE - Cornea
Corneal hysteresis (CH) is gaining recognition as a valuable parameter in the management of glaucoma. Corneal hysteresis is defined as the difference between the inward and outward pressure responses of the cornea during deformation. This measurement reflects the viscoelastic properties...

Diabetic Retinopathy Network laser training programme

5 February 2020 | | EYE - Vitreo-Retinal, EYE - General
The VISION 2020 Diabetic Retinopathy Network (DR-NET) was established in 2014 to tackle the increasing burden of diabetes and diabetic retinopathy (DR) in developing countries [1]. By forming a network of long-term LINK capacity-building partnerships, learning and best practice can...

Toxoplasmosis and the associated retinochoroiditis: important facts and when to treat

1 April 2017 | | EYE - Vitreo-Retinal
Annie SeeWah Tung provides an overview of toxoplasmosis retinochoroiditis, including guidance on which cases should be treated and the treatment options. Toxoplasmosis retinochoroiditis is an infectious condition that is characterised by retinochoroidal lesions commonly in the posterior pole and is...

Assessing everyday visual function in dry AMD – what matters to the person?

1 April 2019 | | EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the primary cause of blindness in the developed world and is accountable for more than one half of sight impairment registrations within England and Wales [1]. AMD is prevalent in people aged 60 years and...

Leading sight organisations to merge

14 August 2020
Two international sight organisations have announced that they will merge from January 2021 to better tackle the global vision crisis.